Title: Chien-Hsing Ken Chang: Innovator in Affinity Enhancement Agents
Introduction
Chien-Hsing Ken Chang is an inventor based in the United States, known for his contributions to the field of affinity enhancement agents. His innovative work focuses on the development of kits that utilize multivalent, multi-specific binding proteins and carrier molecules. Although he currently holds no patents, his research has significant implications in diagnostics and therapeutics.
Latest Patents
Chang's notable invention, titled "Affinity Enhancement Agents," relates to a kit that contains a multivalent, multi-specific binding protein and a carrier molecule. The binding protein features two or more binding sites, with at least one site binding to a hapten moiety and another site binding to a target antigen. The carrier molecule includes a linking molecule that carries a diagnostic agent and/or a therapeutic agent along with two or more haptens. Additionally, the invention encompasses bispecific diabodies that interact with hapten moieties and target antigens, as well as recombinant vectors for expressing these functional diabodies in microbial hosts.
Career Highlights
Throughout his career, Chien-Hsing Ken Chang has worked with prominent companies in the biotechnology sector. He has been associated with Immunomedics, Inc. and Ibc Pharmaceuticals, Inc., where he has contributed to various research and development projects. His expertise in binding proteins and therapeutic agents has positioned him as a valuable asset in the field.
Collaborations
Chang has collaborated with notable professionals, including Edmund A Rossi, enhancing the scope and impact of his research endeavors.
Conclusion
Chien-Hsing Ken Chang's work in affinity enhancement agents showcases his innovative spirit and dedication to advancing biotechnology. His contributions, although not yet patented, hold promise for future developments in diagnostics and therapeutics.